Back to Directory
medical devices logo

Affinity Biosensors | Company Profile

9/24/2025

Contact Information

πŸ‘€
Affinity Biosensors
🏒
Affinity Biosensors
πŸ“
222 E Canon Perdido St, Suite 101, Santa Barbara, California 93101, US

Industry & Market

Primary Industry
medical devices
Location
Santa Barbara, California, United States

Company Metrics

πŸ‘₯Total Employees
11
βš™οΈEngineering
2
πŸ’ΌSales Team
1
πŸ“ˆMarketing
1
πŸ“…Founded
2006
πŸ’°Revenue
70M

Funding Information

Total Funding
$47.7M
Latest Stage
Series a
Annual Revenue
$70,000,000

Headcount Distribution

Total Employees
11
Departments
19

By Department

Department Breakdown

Business Development
Engineering
Accounting
Consulting
Marketing
Operations
Others

Technology Stack

Email & Communication

Outlook
Total: 7 technologies

Keywords & Focus Areas

rapid antimicrobial susceptibility testingpopulation profilingdelayedgrowth phenotypesmedical equipment manufacturingmicrobial population dataresistant strain identificationsingle-cell mass sensingbloodstream infection testinghealthcare equipment and supplies manufacturingphenotypic testinginfection managementdiagnostic automationbiotechnologyai predictorpopulation profiling technologyhigh accuracyresistant bacteria detectionantibiotic effectivenessmedical laboratoriesai-powered mic prediction+10 more
30 total keywords

Affinity Biosensors

Overview

Antimicrobial resistance (AMR) is one of the greatest medical challenges of our time, and this organization is on a mission to deliver the fastest, most actionable diagnostic solutions to save time, save lives, and reduce costs in critical care. The team leverages deep expertise in mass measurement at femtogram levels to transform how healthcare providers identify, manage, and combat infectious diseases.

The FDA-cleared LifeScale AST system redefines antibiotic susceptibility testing by delivering near–real-time insights in approximately 4.5 hours, directly from positive blood cultures. Unlike traditional methods, LifeScale employs a microfluidic sensor that measures individual bacteria with femtogram-level precision, empowering clinicians with vital growth phenotype data to guide more targeted antibiotic therapy. Building on this technology, efforts are expanding into rapid antifungal susceptibility testing to address urgent threats such as Candida auris and further strengthen infection management in hospitals.

With a vision to make every minute count in diagnosing and treating life-threatening infections, the company provides clinicians with timely, accurate data that helps reduce treatment durations, contain costs, and improve patient outcomes.

Basic Information

Industry medical devices
Revenue 70M
Headquarters 222 East Canon Perdido Street, Santa Barbara, California 93101, United States
Languages English

Contact Details

Key Focus Areas & Initiatives

  • Rapid antimicrobial susceptibility testing
  • Population profiling
  • Delayed-growth phenotypes detection
  • Medical equipment manufacturing
  • Microbial population data analysis
  • Resistant strain identification
  • Single-cell mass sensing
  • Bloodstream infection testing
  • Phenotypic resistance testing
  • Infection management
  • Diagnostic automation
  • Biotechnology
  • AI predictor
  • Rapid antifungal susceptibility testing
  • Microfluidic biosensor technology
  • Antibiotic resistance detection
  • Automated inoculation
  • Microfluidic sensor development
  • Sepsis diagnostics
  • Workflow integration for clinical labs

Technologies Used

  • AI
  • Android
  • Cloudflare DNS
  • Hubspot
  • IoT
  • Outlook
  • Remote

Need more information?

Find decision makers, more insights and contact information about this company on Bitscale

Try Bitscale Now

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

SayData

Β© 2025 Bitscale. Featherflow Technology Pvt Ltd

LinkedInTwitterInstagramYouTube